India Glycols Limited
All news and filings related to India Glycols Limited.
View all news & filings- Medium impact
India Glycols subsidiary EBL approves share allotment, new CFO, CS, and auditors
India Glycols subsidiary EBL approved allotment of 2.23 crore equity shares to its shareholders. Key appointments include Ajay Sharma as CFO and Preeti Choudhary as Company Secretary. M/s Mukesh Agarwal & Co. appointed Secretarial Auditor for 5 years, and M/s S.S. Kothari Mehta & Co. LLP as Internal Auditor for FY27.
Read the summary - Medium impact
India Glycols subsidiary IGL Spirits approves share allotment & key appointments
IGL Spirits Limited approved the allotment of 6,70,26,765 equity shares to India Glycols shareholders. Naresh Kumar Agrawal appointed CFO, and Ishan Khanna appointed Company Secretary. MAKS & Co. appointed Secretarial Auditor for five years, and S.S. Kothari Mehta & Co. LLP appointed Internal Auditor for FY26-27.
Read the summary - Low impact
India Glycols to Hold Analyst/Institutional Investor Meeting on Sept 10-11, 2026
India Glycols Limited will host an in-person Analyst/Institutional Investor Meeting in Mumbai on September 10-11, 2026. This non-deal roadshow will discuss publicly available information only.
Read the summary - Low impact
India Glycols Updates on Ennature Bio Pharma Scheme of Arrangement
India Glycols Limited provides a material update on Ennature Bio Pharma Limited's Scheme of Arrangement. This follows observation letters from NSE and BSE dated November 2025. EBL communicated updates on September 7, 2026, in compliance with SEBI regulations.
Read the summary - Medium impact
India Glycols Ltd Receives Material Update on IGL Spirits Scheme of Arrangement
India Glycols Limited received a material update from its subsidiary, IGSL Spirits Limited, regarding a Scheme of Arrangement. The update was communicated on September 7, 2026, in line with SEBI regulations and prior observation letters from NSE and BSE.
Read the summary - Low impact
India Glycols Submits Revised Investor Presentation Post Typo Correction
India Glycols submitted a revised investor presentation on Sept 2, 2026, due to a typo. The company highlighted strong growth in its Potable Spirit segment (+13% revenue) and Biofuels segment (+100% revenue). The demerger, effective Sept 1, 2026, creates three independent listed entities: India Glycols, IGL Spirits, and Ennature Biopharma.
Read the summary - Medium impact
India Glycols Presents Investor Deck Highlighting Demerger & Growth
India Glycols Limited presented an investor deck on September 2, 2026, detailing its demerger into three listed entities. The company targets 10X sales and profits in ten years, driven by sustainable chemistry. Revenue saw a ~13% CAGR and EBITDA ~28% CAGR from FY24-FY26. The demerger aims for sharpened focus and value unlock.
Read the summary - High impact
India Glycols Presents Investor Deck Highlighting Spirits Growth & Bio-fuel Expansion
India Glycols' investor presentation highlights strong growth in its Potable Spirits and Bio-fuels segments. The company aims for significant revenue and EBITDA growth, targeting INR 1,000 Crore EBITDA in 3-4 years. Key strategies include portfolio expansion, market penetration, and strategic partnerships, with a focus on premiumization and leveraging existing capacities.
Read the summary - Medium impact
India Glycols Presents Investor Deck Highlighting Nutraceutical Growth
India Glycols presented an investor deck on Sep 2, 2026, detailing its Ennature Biopharma division. The company is focusing on nutraceutical growth, leveraging its API and Biopolymer businesses. For FY26, revenue was ₹246 crore, EBITDA ₹29 crore. Key strategies include expanding branded nutraceuticals and API offerings.
Read the summary - Low impact
India Glycols: Senior Management Personnel Cease to be SMPs Post-Scheme Effectiveness
India Glycols Limited announced that several Senior Management Personnel ceased to be SMPs as of August 31, 2026. This follows the effectiveness of a Scheme of Arrangement where their employment was transferred to resulting companies. Details are provided as per SEBI regulations.
Read the summary - High impact
India Glycols Demerges into Three Entities Effective September 1, 2026
India Glycols Limited demerged into three entities effective September 1, 2026: India Glycols Limited, IGL Spirits Limited, and Ennature Bio Pharma Limited. Shareholders will receive shares in each new entity based on their holdings as of September 2, 2026.
Read the summary - Low impact
India Glycols to hold Analyst/Institutional Investor Meeting on Sep 2, 2026
India Glycols will host an Analyst/Institutional Investor Meeting on September 2, 2026, in Mumbai. The meeting will commence at 5:00 pm IST and will focus on publicly available information.
Read the summary - Medium impact
India Glycols subsidiary appoints new Chairman, MD, and Directors
IGL Spirits Limited appointed U.S. Bhartia as Chairman & MD for 5 years. Vedant Jhaver and Shirish Barwale appointed as Non-Executive Directors. Samrat Banerjee, Raj Kishore Singh, Vimal Bhandari, and Nidhi Killawala appointed as Independent Directors for 3 years. All appointments effective August 21, 2026, pending shareholder approval.
Read the summary - Low impact
India Glycols Subsidiary Appoints New Directors and KMP
Ennature Bio Pharma Limited, a subsidiary of India Glycols, has appointed Ms. Pragya Bhartia Barwale as Managing Director for five years. Seven new directors, including independent directors, were also appointed. All appointments are effective August 21, 2026, and are subject to shareholder approval.
Read the summary - Medium impact
India Glycols Fixes Sept 1 as Effective Date, Sept 2 as Record Date for Share Allotment
India Glycols Limited set September 1, 2026, as the Effective Date and September 2, 2026, as the Record Date for its Scheme of Arrangement. Shareholders will receive shares in Ennature Bio Pharma Limited and IGSL Spirits Limited based on their holdings in India Glycols.
Read the summary - Medium impact
India Glycols Fixes Sept 1 Effective Date & Sept 2 Record Date for Scheme of Arrangement
India Glycols Limited has set September 1, 2026, as the Effective Date and September 2, 2026, as the Record Date for its Scheme of Arrangement. Shareholders will receive shares in Ennature Bio Pharma and IG L Spirits based on specified ratios.
Read the summary - Low impact
India Glycols Announces Special Window for Physical Share Dematerialization
India Glycols Limited has opened a special window for dematerializing physical shares from February 5, 2026, to February 4, 2027. This applies to shares purchased before April 1, 2019, that were not transferred or were rejected. Re-lodged shares will be under a one-year lock-in post-transfer.
Read the summary - High impact
India Glycols: NCLT Approves Scheme of Arrangement for Demerger
India Glycols Limited received NCLT's order approving the Scheme of Arrangement for demerger. The Scheme separates Biopharma and Spirits/Biofuel undertakings into new entities. The Appointed Date is April 1, 2026. Effective Date and Record Date to be announced. Share swap ratios: 1:3 for Biopharma and 1:1 for Spirits/Biofuel.
Read the summary - High impact
India Glycols Q1 FY27 Earnings Call Transcript Released
India Glycols reported a strong Q1 FY27 with net revenue at ₹1,130 crore (up 9%) and EBITDA at ₹170 crore (up 13%). The company received NCLT approval for demerger of Spirits, Bio-Fuel, and Bio Pharma businesses. Spirits revenue grew 5.3%, Chemicals 20.6%, and Ennature Bio Pharma revenue surged 65%. Finance costs reduced to ₹25 crore.
Read the summary - Low impact
India Glycols Ltd.: AGM Proceedings Concluded Successfully on August 19, 2026
India Glycols Limited's 42nd AGM was held on August 19, 2026. All four resolutions, including financial statement adoption and dividend confirmation, were passed. An interim dividend of ₹7.50 per share was confirmed as final for FY26. Shri Alok Singhal was re-appointed as director.
Read the summary - Low impact
India Glycols Clarifies No Undisclosed Material Information Amidst Volume Surge
India Glycols Limited clarified to BSE that there is no undisclosed material information driving its recent volume surge. The company stated the increased volume appears market-driven and reaffirmed its compliance with SEBI Listing Regulations.
Read the summary - Low impact
India Glycols: No Specific Reason for Volume Surge; Market Driven
India Glycols Limited has clarified to BSE and NSE that there is no undisclosed material information driving the recent increase in trading volume. The company stated the surge appears market-driven and is not aware of any specific reason for it. IGL reaffirmed its compliance with SEBI Listing Regulations.
Read the summary - Low impact
India Glycols Q1FY27 Earnings Conference Call Audio Recording Available
India Glycols Limited has released the audio recording of its Q1FY27 Earnings Conference Call, held on August 14, 2026. The recording is accessible on the company's website.
Read the summary - Low impact
India Glycols: Ms. Pragya Bhartia Barwale Re-designated as Non-Executive Director
India Glycols Limited's Board has re-designated Ms. Pragya Bhartia Barwale from Whole Time Director to Non-Executive Non-Independent Director. This change is effective August 12, 2026. Ms. Barwale is the daughter of the Chairman & Managing Director.
Read the summary - Low impact
India Glycols: Pragya Bhartia Barwale Re-designated to Non-Executive Director
India Glycols Limited's Board approved the re-designation of Ms. Pragya Bhartia Barwale from Whole Time Director to Non-Executive Non-Independent Director. This change is effective August 12, 2026. Ms. Barwale is the daughter of Chairman & Managing Director, Shri U.S. Bhartia.
Read the summary - Medium impact
India Glycols Q1 FY27 Results: Revenue ₹2,987 Cr, Profit ₹76.59 Cr
India Glycols reported Q1 FY27 results with standalone revenue at ₹2,987 crore and consolidated PAT at ₹96.83 crore. Standalone PAT was ₹76.59 crore. EPS stood at ₹11.43. The company is proceeding with its demerger scheme, which has received NCLT sanction.
Read the summary - Low impact
India Glycols to host Q1FY27 Earnings Conference Call on August 14, 2026
India Glycols Limited will conduct its Q1FY27 Earnings Conference Call on August 14, 2026, at 16:00 IST. The call will feature key management personnel including the CEO and CFO. Dial-in details and a web join option are available.
Read the summary - Low impact
India Glycols Announces Q1FY27 Earnings Conference Call on Aug 14
India Glycols Limited will host its Q1FY27 Earnings Conference Call on August 14, 2026, at 16:00 Hrs IST. Key management, including the CEO and CFO, will participate. Dial-in details and contact information for inquiries have been provided.
Read the summary - Medium impact
India Glycols Board Meeting on Aug 12 to Approve Q1 FY27 Results
India Glycols board meeting scheduled for August 12, 2026, to approve Q1 FY27 unaudited financial results (standalone & consolidated). The trading window will be closed until August 14, 2026.
Read the summary - Medium impact
India Glycols Subsidiary Appoints Manoj Kumar Rai as Executive Director & COO
IGL Spirits Limited has appointed Shri Manoj Kumar Rai as Executive Director & Chief Operating Officer. He also joins the board as an Additional Director. The appointment is effective August 4, 2026, for a five-year term ending August 31, 2031.
Read the summary - Low impact
India Glycols Transfers Sr. Manager, Appoints Him Director at Subsidiary
India Glycols Limited transferred Shri Akshay Bansal, Head-Sales & Marketing of Ennature Biopharma Division, to its subsidiary, Ennature Bio Pharma Limited (EBL). He was appointed Additional Director (Executive Director) & KMP at EBL, effective July 31, 2026, for a five-year term.
Read the summary - Low impact
India Glycols: Akshay Bansal Ceases as SMP, Appointed KMP at Subsidiary EBL
India Glycols Limited announced that Shri Akshay Bansal ceased to be a Senior Managerial Personnel from July 30, 2026. He has been appointed as Additional Director (Executive Director) & KMP at its subsidiary, Ennature Bio Pharma Limited (EBL), effective July 31, 2026, for a five-year term.
Read the summary - Low impact
India Glycols Announces 42nd AGM on Aug 19, 2026, to Discuss FY26 Annual Report
India Glycols Limited will hold its 42nd AGM on August 19, 2026, via VC/OAVM. The Annual Report for FY 2025-26 is available online. Shareholders are urged to update their details for electronic dividend payments and AGM participation.
Read the summary - Low impact
India Glycols Ltd. announces 42nd AGM on Aug 19, 2026, with e-voting facility
India Glycols Limited will hold its 42nd AGM on August 19, 2026, via VC/OAVM. The agenda includes approving FY26 financial statements and a final dividend of ₹7.50 per share. E-voting is available from August 15-18, 2026, with August 12, 2026, as the cut-off date.
Read the summary - Low impact
India Glycols announces 42nd AGM on August 19, 2026, via Video Conferencing
India Glycols Limited will hold its 42nd Annual General Meeting on August 19, 2026, via Video Conferencing. The AGM notice and annual report will be sent electronically. Members must update KYC and bank details for dividend payments.
Read the summary - Low impact
India Glycols Announces 42nd AGM on August 19, 2026
India Glycols Limited will hold its 42nd Annual General Meeting (AGM) on August 19, 2026. The meeting will be conducted virtually via Video Conferencing/Other Audio Visual Means. The AGM notice and the Annual Report for FY 2025-26 will be shared with shareholders.
Read the summary - Medium impact
India Glycols' Scheme of Arrangement Sanctioned by NCLT
India Glycols Limited's Scheme of Arrangement has been sanctioned by the NCLT, transferring its Bio Pharma and Spirits & Biofuel undertakings to EBL and ISL, respectively. The Appointed Date is April 1, 2026. The NCLT order was dated July 17, 2026.
Read the summary - Medium impact
India Glycols: NCLT Sanctions Scheme of Arrangement for Demerger
India Glycols Limited's Scheme of Arrangement for demerger of its Bio Pharma, Spirits, and Biofuel undertakings has been sanctioned by the NCLT, Allahabad Bench. The order was pronounced on July 17, 2026. This follows an earlier intimation on July 3, 2026.
Read the summary - Medium impact
India Glycols: NCLT Reserves Order on Scheme of Arrangement
India Glycols Limited announced that the NCLT has reserved its order on the Scheme of Arrangement for demerger. The NCLT reserved the matter on July 2, 2026. The Income Tax Department raised an issue regarding a ₹27,890 demand.
Read the summary - Low impact
India Glycols Limited: Certificate under SEBI Regulations for Q1 FY27
India Glycols Limited received a certificate from its RTA, MCS Share Transfer Agent Limited, for the quarter ended June 30, 2026. The certificate confirms compliance with SEBI (Depositories and Participants) Regulations, 2018 regarding dematerialization of securities.
Read the summary - Low impact
India Glycols Subsidiary Appoints Manoj Kumar Rai as Chief Operating Officer
India Glycols Limited announced that its wholly-owned subsidiary, IGL Spirits Limited, has appointed Shri Manoj Kumar Rai as Chief Operating Officer. The appointment is effective July 2, 2026. Mr. Rai brings over 27 years of experience in various industries.
Read the summary - Low impact
India Glycols Publishes Newspaper Ad on Share Transfer Window & Investor Campaign
India Glycols Limited announced a special window for physical share transfer and dematerialization, open from Feb 5, 2026, to Feb 4, 2027. Additionally, the company supports the "Saksham Niveshak" campaign, urging shareholders to update KYC and bank details by July 9, 2026, to claim unpaid dividends.
Read the summary - Low impact
India Glycols: Notice to Shareholders on IEPF Share Transfer
India Glycols is transferring unpaid/unclaimed shares to IEPF Authority, starting from FY 2018-19. Shareholders must claim outstanding dividends by September 10, 2026. Failure to do so will result in share transfer to IEPF. Details are available on the company website.
Read the summary - High impact
India Glycols Q4 FY26 Earnings Call Transcript Released
India Glycols reported FY26 revenues of ₹9,827 Cr (up 8.7%) and EBITDA of ₹654 Cr (up 24.5%). Q4 FY26 saw net revenues of ₹976 Cr (up 13.1%) and EBITDA of ₹167 Cr (up 13.3%). The company prepaid ₹804 Cr debt, saving ₹20 Cr in interest. Management discussed growth drivers in Bio-Fuels and Potable Spirits.
Read the summary - Medium impact
India Glycols Files Mediation Application for ₹79.76 Crore Insurance Claim
India Glycols filed a Pre-Institution Mediation application on May 21, 2026, against The New India Assurance Co. Limited. IGL seeks to recover ₹79.76 Crore for a rejected insurance claim related to property damage and business interruption at its Kashipur Plant.
Read the summary - Low impact
India Glycols NCLT Hearing Adjourned, Next Date Awaits Notification
India Glycols' NCLT hearing for a Scheme of Arrangement was adjourned on May 21, 2026, due to time constraints. The next hearing date is yet to be announced. This pertains to the restructuring involving India Glycols, Ennature Biopharma, and IGL Spirits.
Read the summary - Low impact
India Glycols Limited: Audio Recording of Q4 & Full Year FY26 Earnings Conference Call Available
India Glycols Limited announced the availability of the audio recording for the Q4 and Full Year FY26 earnings conference call held on 18th May, 2026. The recording is accessible on the company's website.
Read the summary - High impact
India Glycols Q4 & FY26 Results: Revenue Up 11.8%, PAT Up 26.8%
India Glycols Limited reported Q4 FY26 results with Net Revenue up 13.1% to ₹976 Cr and PAT up 35.7% to ₹87 Cr. For FY26, Net Revenue grew 11.8% to ₹4,211 Cr and PAT increased 26.8% to ₹293 Cr. The company's demerger scheme application was admitted by NCLT, with a hearing on May 21, 2026.
Read the summary - High impact
India Glycols Q4 FY26 Results: Net Profit ₹110 Cr, Revenue ₹2,400 Cr
India Glycols Limited reported a net profit of ₹110.28 crore for Q4 FY26, an increase from ₹50.35 crore in Q4 FY25. Full-year FY26 net profit was ₹282.33 crore, up from ₹180.38 crore in FY25. Total income for Q4 FY26 was ₹2,361.40 crore and for FY26 was ₹9,826.20 crore.
Read the summary - Low impact
India Glycols Reappoints Auditors for FY27
India Glycols Limited reappointed M/s. S.S. Kothari Mehta & Co. LLP as Internal Auditors and M/s. R.J. Goel & Co. as Cost Auditors for FY 2026-27. The Board approved these re-appointments on May 14, 2026, based on the Audit Committee's recommendation.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio